A detailed history of Baader Bank Aktiengesellschaft transactions in Novo Nordisk A S stock. As of the latest transaction made, Baader Bank Aktiengesellschaft holds 12,298 shares of NVO stock, worth $595,961. This represents 0.05% of its overall portfolio holdings.

Number of Shares
12,298
Previous 8,000 53.73%
Holding current value
$595,961
Previous $552,000 23.55%
% of portfolio
0.05%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025

BUY
$45.38 - $71.7 $195,043 - $308,166
4,298 Added 53.73%
12,298 $682,000
Q2 2025

Jul 10, 2025

SELL
$58.08 - $81.05 $303,409 - $423,405
-5,224 Reduced 39.5%
8,000 $552,000
Q1 2025

May 08, 2025

BUY
$69.3 - $90.95 $633,956 - $832,010
9,148 Added 224.44%
13,224 $918,000
Q4 2024

Jan 23, 2025

BUY
$85.0 - $120.04 $346,460 - $489,283
4,076 New
4,076 $350,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $109B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Baader Bank Aktiengesellschaft Portfolio

Follow Baader Bank Aktiengesellschaft and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baader Bank Aktiengesellschaft, based on Form 13F filings with the SEC.

News

Stay updated on Baader Bank Aktiengesellschaft with notifications on news.